Cignoken 2% Injection
Marketer
Celon Laboratories Ltd
Salt Composition
Lidocaine (2%)
Overview Cignoken 2% Injection
Cignoken 2% Injection provides localized anesthesia for minor surgical procedures, including dental, oral, diagnostic, and therapeutic interventions. Administered solely by medical professionals, it temporarily blocks pain transmission to the brain, ensuring a comfortable procedure. Generally well-tolerated, minor injection site reactions like pain, swelling, or redness may occur, typically resolving quickly. Persistent numbness or other adverse effects warrant immediate medical attention. Prior to administration, patients with pre-existing heart conditions or those on cardiac medications should inform their physician. Pregnant or breastfeeding individuals should also seek medical counsel. Drowsiness may occur; therefore, avoid driving or operating machinery after injection.
Primary Ingredients of Cignoken 2% Injection
No text was provided. Please provide the text you wish to be rephrased.
Uses of Cignoken 2% Injection
Regional numbing achieved through localized anesthetic.
Major Benefits of Cignoken 2% Injection:
The medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Cignoken 2% Injection:
- Injection site reactions (pain, swelling, redness)
How to use Cignoken 2% Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Cignoken 2% Injection works:
Cignoken 2% Injection provides localized pain relief through a neural blockade. It inhibits nerve impulse transmission, thereby reducing pain perception.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Cignoken 2% Injection concurrently with alcohol. Physician consultation is recommended.
PregnancySAFE IF PRESCRIBED
The injectable medication Cignoken 2% is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no harmful consequences for fetal development; nonetheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Cignoken 2% Injection while breastfeeding appears to pose minimal risk. Available data from human studies indicate negligible danger to the infant.
DrivingSAFE
Administering Cignoken 2% Injection typically does not impair driving capabilities.
KidneyCAUTION
Patients with significant kidney impairment should receive Cignoken 2% Injection with close monitoring. Dosage modification of Cignoken 2% Injection might be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should receive Cignoken 2% Injection with close monitoring. Dosage modifications for Cignoken 2% Injection may be necessary; physician consultation is advised.
What if you forget to take Cignoken 2% Injection :
NA
Facts to Know About Cignoken 2% Injection
| Label | Value |
|---|---|
| Chemical Type | Amide-based compound |
| Developing Habits | No. |
| Type of Therapy | Pain Relievers |
| Action Class | Amide-based local anesthetics |
3,018 People bought this recently